Schedule 13D ownership disclosure
CELLULAR BIOMEDICINE GROUP I
Security class unavailable · CUSIP: 15117P102
Event date: 2020-06-24
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-20-002501
- Form type
- SC 13D
- Filer
- Cellular Biomedicine Group, Inc.
- CIK
- CIK 1378624
- Filed
- Jun 24, 2020
- Reporting period
- Jun 24, 2020
- Description
- Schedule 13D beneficial ownership